CUTR240920P3000
- 1.61
- 0.000.00%
Cutera Newsroom
Energy-based Aesthetic Devices Focused Insights 2024-2029 With Exclusive Data on 44 Vendors Including Key Players Such as Bausch, Cynosure, Cutera, Lumenis, Sinclair, and Sisram Medical - ResearchAndMarkets.com
Earnings Call Summary | Cutera(CUTR.US) Q2 2024 Earnings Conference
Cutera, Inc (CUTR) Q2 2024 Earnings Call Transcript
Cutera Second Quarter 2024 Earnings: Misses Expectations
Cutera's Hold Rating Affirmed Amid Financial Challenges and Operational Headwinds
Cutera | 10-Q: Q2 2024 Earnings Report
Stephens & Co. Maintains Overweight on Cutera, Lowers Price Target to $5
Cutera Price Target Cut to $1.00/Share From $3.00 by Piper Sandler
Cutera Analyst Ratings
Piper Sandler Sticks to Their Hold Rating for Cutera (CUTR)
Cutera Shares Are Trading Lower After the Company Reported Worse-than-expected Q2 Revenue Results and Cut Its FY24 Revenue Guidance.
Is Cutera, Inc. (CUTR) a Good Cosmetic Surgery and Aesthetics Stock to Buy Now?
Express News | Cutera Inc : Stephens Cuts Target Price to $5 From $10
Why Doximity Shares Are Trading Higher By Over 28%; Here Are 20 Stocks Moving Premarket
Cutera: Q2 Earnings Snapshot
Express News | Cutera Inc FY2024 Rev View $161.8 Mln -- LSEG IBES Data
Express News | Cutera Inc - Sees Full Year Revenue Guidance to $140 Million to $145 Million
Express News | Cutera Inc - Cash, Cash Equivalents, and Restricted Cash Guidance Is Updated to About $40 Million at Dec 31
Express News | Cutera - in Qtr Completed Restructuring That Was Initiated in Q4 2023, Which Resulted in Expense Savings of About $20 Mlnon Annualized Basis
Express News | Cutera Inc - Dentified Additional $10 Million Cost Reduction Opportunity in Qtr, Which Should Be Fully Realized in 2025